Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A patient with malignant pleural mesothelioma carrying BRAF V600E mutation responding to vemurafenib.

Lung cancer (Amsterdam, Netherlands) - 1 Feb 2018

Chen Yao, Chen Baisong, Zhu Xiaolian, Zhong Jianping

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Lung Neoplasms
Share to Mesothelioma
Share to Mesothelioma, Malignant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pleural Neoplasms

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Share to Vemurafenib

Source

Identifiers

PMID: 29146159
DOI: 10.1016/j.lungcan.2017.10.013

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A patient with malignant pleural mesothelioma carrying BRAF V600E mutation responding to vemurafenib.PMID 29146159Read ↗

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.Semantic proximity Read ↗

Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.Semantic proximity Read ↗

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib.Semantic proximity Read ↗

BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib.Semantic proximity Read ↗

Successful Treatment of Metastatic Upper Tract Urothelial Carcinoma With Vemurafenib: Case Report.Semantic proximity Read ↗

Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAFV600E-mutant metastatic melanoma.Semantic proximity Read ↗

BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib.Semantic proximity Read ↗

Intrathoracic synovial sarcoma with BRAF V600E mutation.Semantic proximity Read ↗

A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.Semantic proximity Read ↗

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.Semantic proximity Read ↗

Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy.Semantic proximity Read ↗

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.